deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT02285543

A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients

A Randomized Phase II Trial of TPF Induction Chemotherapy in cN2 Patients With Oral Squamous Cell Carcinoma

Sponsor: Shanghai Jiao Tong University School of Medicine

Conditions Carcinoma, Squamous Cell Mouth Neoplasms
Interventions TPF induction chemotherapy radiotherapy surgery
Updated 10 times since 2017 Last updated: Nov 21, 2023 Started: Dec 1, 2016 Primary completion: Jul 30, 2023 Completion: Jul 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No new participants could be enrolled.

Other terminated trials from Shanghai Jiao Tong University School of Medicine

See all terminations from Shanghai Jiao Tong University School of Medicine

Other Carcinoma, Squamous Cell trials with similar outcome

Browse all Carcinoma, Squamous Cell trials

Listed as NCT02285543, this PHASE2 trial focuses on Carcinoma, Squamous Cell and Mouth Neoplasms and remains terminated or withdrawn. Sponsored by Shanghai Jiao Tong University School of Medicine, it has been updated 10 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshotNot Yet Recruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jun 2020 · 24 months · monthly snapshotActive Not Recruiting~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Nov 2022 · 13 months · monthly snapshotRecruiting~Nov 2022 – ~Dec 2023 · 13 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Dec 2023 — Jul 2024 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  4. Nov 2022 — Dec 2023 [monthly]

    Recruiting PHASE2

  5. Oct 2021 — Nov 2022 [monthly]

    Recruiting PHASE2

▶ Show 5 earlier versions

  1. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  2. Jun 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Active Not Recruiting → Recruiting

  3. Jun 2018 — Jun 2020 [monthly]

    Active Not Recruiting PHASE2

  4. Sep 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    Status: Not Yet Recruiting → Active Not Recruiting

  5. Jan 2017 — Sep 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shanghai Jiao Tong University School of Medicine
Data source: Shanghai Jiao Tong University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations